KalVista Pharmaceuticals (KALV) Revenue Growth (1y) (2015 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 30.69% |
| Jan 31, 2020 | -59.46% |
| Oct 31, 2019 | -29.90% |
| Jul 31, 2019 | -9.39% |
| Apr 30, 2019 | -39.55% |
| Jan 31, 2019 | 66.88% |
| Oct 31, 2018 | 396.18% |
| Jul 31, 2018 | 3,772.92% |
| Apr 30, 2018 | 4,145.61% |
| Jan 31, 2018 | 839.92% |
| Oct 31, 2017 | 472.08% |
| Jul 31, 2017 | -90.15% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | -12.50% |
| Sep 30, 2015 | -30.00% |
| Jun 30, 2015 | 40.00% |
| Mar 31, 2015 | 16.67% |